Published in Protein Sci on August 01, 1997
Regulation of the tyrosine kinase Itk by the peptidyl-prolyl isomerase cyclophilin A. Proc Natl Acad Sci U S A (2002) 1.71
Effects of proline cis-trans isomerization on TB domain secondary structure. Protein Sci (1998) 0.82
Purification, crystallization and preliminary crystallographic analysis of the SH2 domain of IL-2-inducible T-cell kinase. Acta Crystallogr Sect F Struct Biol Cryst Commun (2011) 0.77
Improved spectral resolution in cosy 1H NMR spectra of proteins via double quantum filtering. Biochem Biophys Res Commun (1983) 7.26
Influence of proline residues on protein conformation. J Mol Biol (1991) 4.87
Helix geometry in proteins. J Mol Biol (1988) 4.66
Consideration of the Possibility that the slow step in protein denaturation reactions is due to cis-trans isomerism of proline residues. Biochemistry (1975) 4.65
Hypothesis about the function of membrane-buried proline residues in transport proteins. Proc Natl Acad Sci U S A (1986) 2.90
Folding of immunogenic peptide fragments of proteins in water solution. I. Sequence requirements for the formation of a reverse turn. J Mol Biol (1988) 2.30
Occurrence and role of cis peptide bonds in protein structures. J Mol Biol (1990) 2.06
Proline motifs in peptides and their biological processing. FASEB J (1995) 1.69
Proline isomerism leads to multiple folded conformations of calbindin D9k: direct evidence from two-dimensional 1H NMR spectroscopy. Proc Natl Acad Sci U S A (1989) 1.19
Use of proline mutants to help solve the NMR solution structure of type III antifreeze protein. Protein Sci (1993) 1.19
Multiple conformations and proline cis-trans isomerization in salmon calcitonin: a combined nuclear magnetic resonance, distance geometry, and molecular mechanics study. Biochemistry (1994) 0.91
1H- and 13C-NMR investigations on cis-trans isomerization of proline peptide bonds and conformation of aromatic side chains in H-Trp-(Pro)n-Tyr-OH peptides. Biopolymers (1993) 0.89
Multiple conformations of the sea anemone polypeptide anthopleurin-A in solution. Protein Sci (1994) 0.84
Interleukin-3 enhances the endogenous leukotriene production. Blood (1993) 0.82
Potent interleukin 3 receptor agonist with selectively enhanced hematopoietic activity relative to recombinant human interleukin 3. Proc Natl Acad Sci U S A (1995) 0.80
Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest (1989) 5.71
Structural insights into the stereochemistry of the cyclooxygenase reaction. Nature (2000) 1.79
Kinetic and structural evidence for a sequential ordered Bi Bi mechanism of catalysis by Saccharomyces cerevisiae myristoyl-CoA:protein N-myristoyltransferase. J Biol Chem (1991) 1.34
D-cycloserine, a positive modulator of the N-methyl-D-aspartate receptor, enhances performance of learning tasks in rats. Pharmacol Biochem Behav (1989) 1.29
Genetic studies reveal that myristoylCoA:protein N-myristoyltransferase is an essential enzyme in Candida albicans. Mol Microbiol (1995) 1.20
Genetic and biochemical studies establish that the fungicidal effect of a fully depeptidized inhibitor of Cryptococcus neoformans myristoyl-CoA:protein N-myristoyltransferase (Nmt) is Nmt-dependent. J Biol Chem (1998) 1.12
Effects of Histoplasma capsulatum on murine macrophage functions: inhibition of macrophage priming, oxidative burst, and antifungal activities. Infect Immun (1989) 1.10
A comparative analysis of the kinetic mechanism and peptide substrate specificity of human and Saccharomyces cerevisiae myristoyl-CoA:protein N-myristoyltransferase. J Biol Chem (1993) 1.09
The glycoprotease of Pasteurella haemolytica A1 eliminates binding of myeloid cells to P-selectin but not to E-selectin. Biochem Biophys Res Commun (1992) 1.08
Structural and functional studies of Saccharomyces cerevisiae myristoyl-CoA:protein N-myristoyltransferase produced in Escherichia coli. Evidence for an acyl-enzyme intermediate. J Biol Chem (1990) 1.02
Novel assay for the influenza virus M2 channel activity. FEBS Lett (1995) 1.02
Functional analysis of protein N-myristoylation: metabolic labeling studies using three oxygen-substituted analogs of myristic acid and cultured mammalian cells provide evidence for protein-sequence-specific incorporation and analog-specific redistribution. Proc Natl Acad Sci U S A (1990) 1.02
N-myristoylation of Arf proteins in Candida albicans: an in vivo assay for evaluating antifungal inhibitors of myristoyl-CoA: protein N-myristoyltransferase. Microbiology (1997) 1.00
Secretion of active kringle-2-serine protease in Escherichia coli. Biochemistry (1990) 1.00
Inhibition of synaptosomal calcium uptake by ethanol. J Pharmacol Exp Ther (1980) 0.96
Selective peptidic and peptidomimetic inhibitors of Candida albicans myristoylCoA: protein N-myristoyltransferase: a new approach to antifungal therapy. Biopolymers (1997) 0.96
Novel biologically active nonpeptidic inhibitors of myristoylCoA:protein N-myristoyltransferase. J Med Chem (1998) 0.94
Identification, purification, and characterization of truncated forms of the human nerve growth factor receptor. J Biol Chem (1989) 0.94
Excitatory amino acid receptor potency and subclass specificity of sulfur-containing amino acids. J Neurochem (1987) 0.93
MyristoylCoA:protein N-myristoyltransferase. Adv Enzymol Relat Areas Mol Biol (1993) 0.92
Isothermal titration calorimetric studies of Saccharomyces cerevisiae myristoyl-CoA:protein N-myristoyltransferase. Determinants of binding energy and catalytic discrimination among acyl-CoA and peptide ligands. J Biol Chem (1994) 0.90
Saturation mutagenesis of human interleukin-3. J Biol Chem (1995) 0.89
Safety assessment of the neomycin phosphotransferase II (NPTII) protein. Biotechnology (N Y) (1993) 0.88
Removal of "tightly bound" nucleotides from soluble mitochondrial adenosine triphosphatase (F1). J Biol Chem (1976) 0.87
Three-dimensional solution structure and backbone dynamics of a variant of human interleukin-3. J Mol Biol (1996) 0.87
Design and syntheses of potent and selective dipeptide inhibitors of Candida albicans myristoyl-CoA:protein N-myristoyltransferase. J Med Chem (1995) 0.86
Conformationally constrained [p-(omega-aminoalkyl)phenacetyl]-L-seryl-L-lysyl dipeptide amides as potent peptidomimetic inhibitors of Candida albicans and human myristoyl-CoA:protein N-myristoyl transferase. J Med Chem (1997) 0.86
A new hypothesis based on suicide substrate inhibitor studies for the mechanism of action of aromatase. Cancer Res (1982) 0.84
Purification and characterization of the membrane adenosine triphosphatase complex from the wild-type and N,N'-dicyclohexylcarbodiimide-resistant strains of Streptococcus faecalis. J Bacteriol (1981) 0.84
Characterization of a [3H]glycine recognition site as a modulatory site of the N-methyl-D-aspartate receptor complex. J Neurochem (1989) 0.83
Practical aspects of fluorescent staining for proteomic applications. Electrophoresis (2001) 0.83
Removal of "tightly bound" nucleotides from phosphorylating submitochondrial particles. J Biol Chem (1976) 0.81
Conformational unfolding in the N-terminal region of ribonuclease A detected by nonradiative energy transfer. Biochemistry (1986) 0.81
Use of combinatorial mutagenesis to select for multiply substituted human interleukin-3 variants with improved pharmacologic properties. Exp Hematol (1999) 0.80
Use of photoactivatable peptide substrates of Saccharomyces cerevisiae myristoyl-CoA:protein N-myristoyltransferase (Nmt1p) to characterize a myristoyl-CoA-Nmt1p-peptide ternary complex and to provide evidence for an ordered reaction mechanism. Proc Natl Acad Sci U S A (1993) 0.80
Irreversible inhibition by acetaldehyde of cholecystokinin-induced amylase secretion from isolated rat pancreatic acini. Biochem Pharmacol (1985) 0.80
Potent interleukin 3 receptor agonist with selectively enhanced hematopoietic activity relative to recombinant human interleukin 3. Proc Natl Acad Sci U S A (1995) 0.80
Hydroperoxides as inactivators of aromatase: 10 beta-hydroperoxy-4-estrene-3,17-dione, crystal structure and inactivation characteristics. Biochemistry (1984) 0.80
Purification and characterization of microbially expressed neomycin phosphotransferase II (NPTII) protein and its equivalence to the plant expressed protein. Biotechnology (N Y) (1993) 0.80
Large-scale production of HIV-1 protease from Escherichia coli using selective extraction and membrane fractionation. Protein Expr Purif (1995) 0.80
1H, 13C, and 15N NMR resonance assignments, secondary structure, and backbone topology of a variant of human interleukin-3. Biochemistry (1995) 0.79
Circular permutation of granulocyte colony-stimulating factor. Biochemistry (1999) 0.79
Renaturation and purification of human tissue factor pathway inhibitor expressed in recombinant E. coli. Protein Expr Purif (1994) 0.79
Effects of guanine nucleotides on N-methyl-D-aspartate receptor-ligand interactions. Mol Pharmacol (1988) 0.79
The receptor binding site of human interleukin-3 defined by mutagenesis and molecular modeling. J Biol Chem (1997) 0.79
Identification of a novel structural class of positive modulators of the N-methyl-D-aspartate receptor, with actions mediated through the glycine recognition site. Eur J Pharmacol (1990) 0.78
High level expression and refolding of mouse interleukin 4 synthesized in Escherichia coli. J Biol Chem (1995) 0.78
Enzyme-generated intermediates derived from 4-androstene-3,6,17-trione and 1,4,6-androstatriene-3,17-dione cause a time-dependent decrease in human placental aromatase activity. Endocrinology (1981) 0.78
Characterization of glycosylated bovine placental lactogen and the effect of enzymatic deglycosylation on receptor binding and biological activity. Endocrinology (1990) 0.78
Conformational unfolding in the N-terminal region of ribonuclease A detected by nonradiative energy transfer: distribution of interresidue distances in the native, denatured, and reduced-denatured states. Biopolymers (1988) 0.78
Tightly-bound ATP and ADP in reconstituted submitochondrial particles. Biochem Biophys Res Commun (1978) 0.78
Circular permutation of the granulocyte colony-stimulating factor receptor agonist domain of myelopoietin. Biochemistry (1999) 0.78
Progenipoietins: biological characterization of a family of dual agonists of fetal liver tyrosine kinase-3 and the granulocyte colony-stimulating factor receptor. Exp Hematol (2001) 0.78
Bivalent binding and signaling characteristics of Leridistim, a novel chimeric dual agonist of interleukin-3 and granulocyte colony-stimulating factor receptors. Exp Hematol (2001) 0.77
Glycine modulation of the phencyclidine binding site in mammalian brain. Brain Res (1988) 0.77
Accessibility of the alpha chains in membrane-bound and solubilized bacterial ATPase to chymotryptic cleavage. Biochem Biophys Res Commun (1978) 0.77
Amphotericin B selectively stimulates macrophages from high responder mouse strains. Immunopharmacol Immunotoxicol (1991) 0.77
Purification and characterization of pituitary bovine somatotropin. J Biol Chem (1989) 0.77
10 beta-propynyl-substituted steroids. Mechanism-based enzyme-activated irreversible inhibitors of estrogen biosynthesis. J Biol Chem (1981) 0.77
Large-scale production and characterization of Bacillus thuringiensis subsp. tenebrionis insecticidal protein from Escherichia coli. Appl Microbiol Biotechnol (1997) 0.75
Utilization of multiple phage display libraries for the identification of dissimilar peptide motifs that bind to a B7-1 monoclonal antibody. Mol Divers (1996) 0.75
Effects of pentobarbital, ethanol and morphine on subcellular localization of calcium and magnesium in brain. Biochem Pharmacol (1979) 0.75
Studies of the inactivation of human placental aromatase by 17 alpha-ethynyl-substituted 10 beta-hydroperoxy and related 19-nor steroids. Biochem Pharmacol (1986) 0.75
Differential modulation of the associated glycine recognition site by competitive N-methyl-D-aspartate receptor antagonists. Mol Pharmacol (1990) 0.75
Characterization of D-3,4-cyclopropylglutamates as N-methyl-D-aspartate receptor agonists. Neurosci Lett (1990) 0.75
Determination of the pharmacokinetics of 2-amino-7-phosphonoheptanoate in rat plasma and cerebrospinal fluid. Neurosci Lett (1988) 0.75
Cis-2,4-methanoglutamate is a potent and selective N-methyl-D-aspartate receptor agonist. Eur J Pharmacol (1990) 0.75
Evidence for a functional coupling of the NMDA and glycine recognition sites in synaptic plasma membranes. Eur J Pharmacol (1990) 0.75
Effects of depressant drugs and sulfhydryl reagents on the transport of calcium by isolated nerve endings. Biochem Pharmacol (1980) 0.75
Aromatase enzyme catalysis is involved in the potent inhibition of estrogen biosynthesis caused by 4-acetoxy- and 4-hydroxy-4-androstene-3, 17-dione. Mol Pharmacol (1982) 0.75
Synthesis, absolute configuration and activity at N-methyl-D-aspartic acid (NMDA) receptor of the four D-2-amino-4,5-methano-adipate diastereoisomers. Farmaco (1991) 0.75
Promegapoietin, a family of chimeric growth factors, supports megakaryocyte development through activation of IL-3 and c-Mpl ligand signaling pathways. Exp Hematol (2001) 0.75
Characterization of 3-carboxy-5-phosphono-1,2,3,4-tetrahydroisoquinoline (SC-48981), a potent competitive N-methy-D-aspartate (NMDA) receptor antagonist, in vitro and in vivo. Neurosci Lett (1992) 0.75
Novel indole-2-carboxylates as ligands for the strychnine-insensitive N-methyl-D-aspartate-linked glycine receptor. J Med Chem (1991) 0.75
The enhanced in vitro hematopoietic activity of leridistim, a chimeric dual G-CSF and IL-3 receptor agonist. Leukemia (2002) 0.75
Crystallization of a chymotrypsin inhibitor from Erythrina caffra seeds. J Mol Biol (1990) 0.75
Peptide mapping of bovine pancreatic ribonuclease A by reverse-phase high-performance liquid chromatography. I. Application to the reduced and S-carboxymethylated protein. Anal Biochem (1984) 0.75